Creyon Bio and Eli Lilly Forge Partnership to Develop RNA-Targeted Oligonucleotide Therapies Creyon Bio, Inc., a leader in innovative RNA-targeted therapies, has announced a transformative global licensing and multi-target research collaboration with Eli Lilly and Company, one of the world’s…
Qualthera Health Launches R&D Subsidiary for Drug Repurposing and Novel Delivery Qualthera Pharmaceuticals Ltd. Co. aims to reshape the future of therapeutics through a patient-driven, data-informed approach to repurposing proven compounds and revolutionizing drug delivery systems. Qualthera Health Corporation, a…
IFF Pharma Solutions Set to Highlight Its Portfolio at Excipient World 2025 IFF Pharma Solutions, a division of International Flavors & Fragrances Inc. and a global leader in polymer innovation, is preparing to take center stage at Excipient World 2025.…
Prilenia and Ferrer Partner on Pridopidine Commercialization and Development in Europe Prilenia Therapeutics B.V., a clinical-stage biopharmaceutical company dedicated to developing transformative therapies for neurodegenerative diseases, announced a significant new collaboration and license agreement with Ferrer, an international pharmaceutical company…
Revolution Medicines Shares Early Zoldonrasib Data in KRAS G12D NSCLC at 2025 AACR Revolution Medicines, Inc. a late-stage clinical oncology company committed to developing targeted therapies for patients with RAS-addicted cancers, today unveiled new clinical data on zoldonrasib (RMC-9805), a…
Lumicera and Costco Partner to Offer Cost-Plus Specialty Pharmacy with Enhanced Pricing and Patient Support In a move poised to shake up the specialty pharmacy market, Lumicera Health Services, a nationally recognized provider of specialty pharmacy solutions, has announced a…
Debiopharm and Oncodesign Services Partner to Advance Radiopharmaceuticals in Preclinical Research Debiopharm Research & Manufacturing S.A. (Debiopharm), a privately held, Swiss-based global biopharmaceutical company committed to advancing the treatment landscape for cancer and infectious diseases, has announced a strategic licensing…
CN Bio and Pharmaron Forge Long-Term Global Partnership for OOC Tech Development In a significant stride toward revolutionizing preclinical drug development, CN Bio, a leading innovator in Organ-on-a-Chip (OOC) technologies, has entered into a strategic partnership with Pharmaron, one of…
FDA Grants Breakthrough Status to BrainChild Bio’s CAR T Therapy for Pediatric Brain Tumors BrainChild Bio, Inc., a clinical-stage biotechnology company at the forefront of neuro-oncology cell therapy innovation, has achieved a significant regulatory milestone with the announcement that its…
Secretome Therapeutics Names Dr. Marshelle Smith Warren as New Chief Medical Officer Secretome Therapeutics, a pioneering clinical-stage biotechnology company dedicated to advancing therapies derived from neonatal cardiac progenitor cells (nCPCs), is pleased to announce the appointment of Marshelle Smith Warren,…
Biostate AI and Weill Cornell Join Forces to Harness AI for Tailored Leukemia Therapies In a groundbreaking move that combines the power of artificial intelligence (AI) with cutting-edge medical research, Biostate AI, a leader in artificial intelligence-driven RNA sequencing, has…
ATCC Expands Leadership Team Through Senior Executive Appointments In a move that underscores its commitment to advancing science and strengthening operational excellence, ATCC, the global leader in biological materials management and standards, has announced a series of pivotal leadership appointments…